Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.63%

Sanofi (SNY)

-NYSE
48.92 Down 0.36(0.73%) 4:02PM EDT
Add to Portfolio
Prev Close:49.28
Open:49.41
Bid:48.76 x 100
Ask:51.41 x 100
1y Target Est:57.50
Beta:0.879506
Next Earnings Date:N/A
Day's Range:48.92 - 49.55
52wk Range:43.57 - 57.42
Volume:1,805,719
Avg Vol (3m):1,725,610
Market Cap:127.79B
P/E (ttm):23.58
EPS (ttm):2.08
Div & Yield:1.61 (3.21%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):15.01
P/S (ttm):3.12
Ex-Dividend Date:06-May-15

Analysts

Annual EPS Est (Dec-15) :3.17
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):1.78

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sanofi researches, develops, and markets various therapeutic solutions. Its products comprise diabetes solutions, including Lantus, Apidra, and Insuman that are human insulin analogs; Amaryl, an oral sulfonylurea; Lyxumia, a glucagon-like peptide-... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback